Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist

2005/10/06 by Christopher J. Langmead, Victoria A. H. Fry, Victoria AH. Fry +6 · 108 citations
Biochemistry, Genetics and Molecular Biology · Chemistry · Neuroscience · #Biochemistry #Chemistry #Medicinal chemistry #Muscarinic acetylcholine receptor #Neuroscience and Neuropharmacology Research #Piperidine #Protein Kinase Regulation and GTPase Signaling #Receptor #Receptor Mechanisms and Signaling #Stereochemistry

paper · doi:10.1124/mol.105.017814

published in Molecular Pharmacology 69(1), 236-246 (American Society for Pharmacology and Experimental Therapeutics)

openalex publication_date 2005/10/06 · openalex created_date 2016/06/24 · openalex updated_date 2026/07/28

Citations

• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
• Systematic risk behavior of financially distressed firms

Cited by

• The Best of Both Worlds? Bitopic Orthosteric/Allosteric Ligands of G Protein–Coupled Receptors
• Keynote review: allosterism in membrane receptors. [europepmc]
• Structure-activity relationships of new 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric enhancers of the A3 adenosine receptor. [europepmc]
• Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties. [europepmc]
• Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen. [europepmc]
• Allosteric modulation of muscarinic acetylcholine receptors. [europepmc]
• Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential. [europepmc]
• Facilitation of long-term potentiation by muscarinic M(1) receptors is mediated by inhibition of SK channels. [europepmc]
• Development of a highly selective, orally bioavailable and CNS penetrant M1 agonist derived from the MLPCN probe ML071. [europepmc]
• Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M(1) receptor function in the central nervous system. [europepmc]
• Approaches for probing allosteric interactions at 7 transmembrane spanning receptors. [europepmc]
• Monoclonal anti-β1-adrenergic receptor antibodies activate G protein signaling in the absence of β-arrestin recruitment. [europepmc]
• Muscarinic acetylcholine receptors: novel opportunities for drug development. [europepmc]
• ATP and Odor Mixture Activate TRPM5-Expressing Microvillous Cells and Potentially Induce Acetylcholine Release to Enhance Supporting Cell Endocytosis in Mouse Main Olfactory Epithelium. [europepmc]
• Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer's Disease. [europepmc]
• The operational model of allosteric modulation of pharmacological agonism. [europepmc]
• Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders. [europepmc]
• Multitargeting nature of muscarinic orthosteric agonists and antagonists. [europepmc]